This Center focuses on developing new treatments for rare, ultra-rare and rare variants of common diseases.
Harrington Discovery Institute and The University of Oxford have formed a unique partnership combining world-leading strengths in research and therapeutics development. The Oxford-Harrington Centre advances knowledge into cures for rare diseases across the United Kingdom and the United States.
University Hospitals Health System, Inc. of Cleveland, Ohio, USA established Fund for Cures UK, Ltd. (Fund for Cures UK) to make grants and establish affiliations or centers of excellence to advance scientific discoveries into medicines. Fund for Cures UK operates in the UK and makes charitable grants to leading universities, medical schools, research institutes, and other charitable and scientific institutions.
Oxford-Harrington Rare Disease Centre Opens Call for Proposals
The Oxford-Harrington Rare Disease Centre Launches Pioneering Therapeutics Accelerator to Advance Innovative Treatments for Rare Diseases
AleveoGene Launches to Develop Unique Inhaled Gene Therapies for Rare Respiratory Disorders
Click the points on the map below to see our scholar institutions
Accelerates breakthrough academic discoveries into new treatments for patients with rare diseases.
2024 Rare Disease Day Webinar
Advancing Hope for Patients with Huntington's Disease
Harrington Discovery Institute Brings Families Hope
Professor Matthew Wood
Director, Oxford-Harrington Rare Disease Centre; Professor of Neuroscience, University of Oxford
Matthew P. Anderson, MD, PhD
Co-Director, Oxford-Harrington Rare Disease Centre; Investigator, Harrington Discovery Institute; Visiting Professor, University of Oxford
Sir John Bell
President, Ellison Institute of Technology, Oxford; Interim Council Chairperson
Georg Holländer, MD
Head of Department of Paediatrics, University of Oxford
Jonathan Stamler, MD
President, Harrington Discovery Institute
